Professional background
Dr Saima Riaz has been a member of the medical team at the Institute of Nuclear Medicine since 2021.
Her clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
Specialties
Research interests
New radionuclide therapy tracers
Languages spoken
Urdu
Publications
18 journal articles including:
Molecular radionuclide therapy-induced salivary gland toxicity: an unappreciated threat to patients' quality of life?
Stefan Vöö, Valeria Mercadante, Saima Riaz, Sarah Algodayan, Catherine Scott, Dimitris Priftakis, Martina Shephard, Jamshed Bomanji.Nucl Med Commun. 2024 Jul 1;45(7):547-549
The value of 18F-FDG PET-CT and 131I-norcholesterol scintigraphy in the characterisation of high-risk adrenal masses.
Saima Riaz, Rizwan Syed, Tarek Abdel Aziz, Abdulrahman Alnaim, Teng Teng Chung, Simon Wan,Tom R Kurzawinski, Jamshed Bomanji. Nucl Med Commun. 2020 Mar;41(3):189-195.
Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival.
Hassan A, Siddique M, Riaz S, Khan AI, Nawaz MK, Bashir H. J Ayub Med Coll Abbottabad. 2018 Oct-Dec;30(Suppl 1)(4):S627-S632.